News & Analysis on Clinical Trial Services & Contract Research And Development
PharmaCyte Biotech has contracted Medpace to conduct the clinical trial using its novel live-cell encapsulation technology, Cell-in-a-Box, which the company says could revolutionize cancer treatment.
STA Pharmaceutical has entered an agreement with China-based Antengene to provide R&D for its oncology pipeline using its ‘end-to-end’ CMC platform.
The MA-based CRO Veristat is partnering with Triumph Research Intelligence to provide centralized and risk-based monitoring solutions to improve clinical trial compliance.
Parexel is adopting Medidata’s Shyft Analytics platform to bolster its real-world evidence generation and outcomes research offering to biopharmaceutical and medical device clients.
India-headquartered Glenmark Pharmaceuticals has opened a 100,000-square-foot facility on the East Coast for the manufacture of fixed dose formulations.
Takeda Pharmaceutical will hold an investor vote next month on the $62bn acquisition of rare disease specialist, Shire.
Immuno-oncology clinical trials are fundamentally different from traditional oncology studies as it pertains to logistics, and require close coordination across several stakeholders, says CRO.
Supply chain companies have been busy in 2018. Here, we're wrapping up some of the big moves made over the last year.
To manage the supply chain challenges faced by natural disasters, experts say to expect the unexpected – ensuring a strong shipping strategy is in place with temperature control and robust management.
Tracking the chain of custody for trial kits and ensuring patient data blinding – in compliance with HIPPA and GDPR – are among the unique logistical challenges to direct-to-patient clinical trials.
Q&A
Securing the clinical supply chain comes down to the notion of ‘compliance’, which is transitioning from a ‘nice to have’ to a ‘need to have,’ says Cryoport.